ATLASAura Biosciences (AURA) earnings date: Nov 5, 2026
Aura Biosciences (AURA) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 5, 2026, after the close. Analysts expect EPS of -$0.31.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on AURA
| Last price | $6.02 (-2.0%) |
|---|---|
| Normal 1-day range (±1σ) | ±2.8% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Aura Biosciences stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Aura Biosciences reports on Nov 5, 2026. One email the day before, with ATLAS’s read on Aura Biosciences. You can switch it off at any time.
Alert me before AURA reportsFree to start. Creating an account takes under a minute.
Notify me when Aura Biosciences reports
Track AURA free Add Aura Biosciences to a free ATLAS watchlist and see its next report date in one place.
AURA earnings at a glance
| Next report (confirmed) | Thu, Nov 5, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.31 |
| Last report | Aug 11, 2026 · Miss |
| Beat rate (last 4 reports) | 2 of 4 (50%) |
| Average EPS surprise | +2.6% |
| Average move around a report | ±4.6% (last 4) |
| Sector | Healthcare · Biotechnology |
Aura Biosciences earnings history: last 4 reports
Aura Biosciences last reported on Aug 11, 2026: EPS of -$0.48 against an estimate of -$0.37 (-29.7% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 11, 2026 | -$0.37 | -$0.48 | -29.7% | Miss | +0.7% |
| Jun 18, 2026 | -$0.20 | -$0.08 | +60.0% | Beat | +10.1% |
| May 11, 2026 | -$0.40 | -$0.50 | -25.0% | Miss | -5.6% |
| Apr 18, 2026 | $0.39 | $0.41 | +5.1% | Beat | +2.1% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for AURA
See the fair value, the probability range and the earnings history of Aura Biosciences on its ATLAS page.
Aura Biosciences (AURA) stock analysisPlans from €3.99 a month.
Aura Biosciences earnings: frequently asked questions
When does Aura Biosciences (AURA) report earnings?
Aura Biosciences is scheduled to report on Thursday, November 5, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for AURA?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.31 per share (USD). Estimates can change before the report.
How often does AURA beat earnings estimates?
Of its last 4 reports with a recorded result, Aura Biosciences beat the EPS estimate 2 times; the average surprise was +2.6%. Past results do not predict the next one.
How much does AURA move around earnings?
Over its last 4 reports the stock moved an average of 4.6% (absolute, from the close before the report day to the close after it), and finished higher 3 of 4 times.
Did Aura Biosciences beat earnings estimates last quarter?
Aura Biosciences last reported on Aug 11, 2026: EPS of -$0.48 against an estimate of -$0.37 (-29.7% surprise), a miss.
How much does AURA usually move in a day?
On a normal trading day the ATLAS model puts AURA’s one-day range at about ±2.8%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 5, 2026
Educational information, not investment advice. Disclaimer